End TB Strategy top 10 indicators: current status in participant countries

Size: px
Start display at page:

Download "End TB Strategy top 10 indicators: current status in participant countries"

Transcription

1 End TB Strategy top 10 indicators: current status in participant countries Dennis FALZON Global TB Programme, WHO/HQ Geneva Regional WHO / Global Fund meeting Kenya 20 September 2016

2 Objectives of the presentation 1. Summarize the main findings of the country survey of 5 of the top 10 indicators 2. Identify the main challenges in the generation of the indicators 3. Propose a framework to prioritize countryand indicator-specific solutions for investment

3 End TB Strategy top 10 indicators 1. TREATMENT COVERAGE 2. TREATMENT SUCCESS RATE 3. HOUSEHOLDS WITH CATASTROPHIC COSTS DUE TO TB 4. TB PATIENTS TESTED WITH A WRD AT DIAGNOSIS 5. LTBI TREATMENT COVERAGE 6. CONTACT INVESTIGATION COVERAGE 7. DST COVERAGE FOR TB PATIENTS 8. TREATMENT COVERAGE, NEW TB DRUGS 9. DOCUMENTATION OF HIV STATUS AMONG TB PATIENTS 10. CASE FATALITY RATIO

4 1. TREATMENT COVERAGE All TB MDR/RR-TB Source:

5 2. TREATMENT SUCCESS RATIO All TB (new & relapse, 2014) MDR/RR-TB, 2013 Source:

6 9. DOCUMENTATION OF HIV STATUS AMONG TB PATIENTS Source: WHO Global tuberculosis report 2015 (WHO/HTM/TB/ )

7 10. CASE FATALITY RATIO Source: WHO Global tuberculosis report 2015 (WHO/HTM/TB/ )

8 SUMMARY OF SURVEY REPLIES FOR NEW INDICATORS

9 4. TB PATIENTS TESTED WITH A WRD AT DIAGNOSIS % new & relapse cases diagnosed with a WRD Country BMU register compatible? Registers provide: Numerator Denominator Benin YES???? Ethiopia YES YES YES?? Kenya YES YES YES YES Malawi YES YES YES?? Mozambique YES YES YES?? Nigeria YES???? South Africa YES YES YES?? Swaziland YES YES YES?? Uganda YES YES YES?? Indicator generated? UR Tanzania YES NO NO Relapses reported under retreatment ; need to go to Rx card and lab register Zimbabwe YES YES YES??

10 5. LTBI TREATMENT COVERAGE % eligible household contacts <5 years started on LTBI treatment Country Data sources Numerator Denominator Aggregated data at national level? Benin Rx card of index c. & IPT register YES YES Yes (indicator generated quarterly ) Ethiopia TB register YES YES No Kenya TB register, others YES NO Yes Malawi TB register, others YES YES Yes Mozambique Contact register YES YES Yes Nigeria Special register YES YES Yes (<6y contact of bact+) South Africa Rx card of index c. YES NO No Swaziland Uganda Soon new contact & IPT registers TB, IPT & contact registers, er&r - - No YES YES Yes & No (? Developing) UR Tanzania Not captured - - No Zimbabwe contact & IPT registers; DHIS2 YES YES Yes

11 6. CONTACT INVESTIGATION COVERAGE % eligible contacts of bact.-confirmed TB evaluated for TB Country Data sources Registers provide: Indicator generated? Numerator Denominator Benin Not captured - - NO; no national guidance Ethiopia TB register YES YES NO Kenya TB register (low completeness) - -?more data from partners Malawi TB & contact registers YES YES YES; use special DCF Mozambique Contact register YES YES YES Nigeria New register & report YES YES NO (to start soon) South Africa Rx card of index SOME NO NO Swaziland Not captured - - New registers soon Uganda Not captured - - UR Tanzania Not captured - - NO Zimbabwe TB register YES YES NO

12 7. DST COVERAGE FOR TB PATIENTS % TB cases with DST results for at least rifampicin Country BMU register compatible? Registers provide: Numerator Denominator Benin YES?YES?YES?? Ethiopia???????? Kenya YES YES YES?? Indicator being generated? Malawi YES YES YES YES; use special logbook Mozambique YES YES YES? possibly Nigeria YES YES YES? South Africa YES YES YES?? Swaziland YES YES YES?? Uganda YES YES YES YES UR Tanzania YES?YES?YES?? Zimbabwe YES YES YES YES; DHIS2 at facility level

13 Country 8. TREATMENT COVERAGE, NEW TB DRUGS % eligible TB cases on bedaquiline or delamanid New TB drugs available? Data on R&R system? Data sources Eligibility recorded? Benin YES YES List of RR-TB/pre-/XDR cases? Ethiopia YES NO - - Kenya YES YES Rx logbook; facility and electronic register s Malawi NO - Will be updated if new drugs introduced Mozambique NO - - NO Nigeria NO - Expected in 2017? South Africa YES YES Electronic register YES Swaziland YES YES DR-TB register; new tools YES Uganda YES YES DR TB unit Register and NTRL DST reports UR Tanzania YES NO RR-TB list; SLD Rx card YES Zimbabwe NO NO To be updated as new drugs? YES - YES

14 INDICATORS BEING DERIVED ALREADY? Country 4 WRD 5 LTBI Rx 6 Contact 7 DST 8 New Rx Benin?????? Ethiopia???? Kenya???? Malawi?? No Bdq Mozambique???? No Bdq Nigeria???? No Bdq South Africa?????? Swaziland?????? Uganda???? UR Tanzania?? Zimbabwe?? No Bdq

15 Conceptual framework to focus on the main challenges Score the relative challenges to derive each indicator in your country (least 1-> most 6) Data source (e.g. accessing data from laboratories or from inexistent vital registration systems) Disaggregation (e.g. data available but not collected in a manner which permits certain aggregations/summarization) Data management (e.g. inefficiencies of paper-based registers; no automated dashboards to summarize the indicators) Definitional (e.g. user understanding of what is a contact, how to define a cure or validity of drug resistance results data) Indicators Resources (e.g. lack of staff devoted to M & E; no investment in electronic surveillance) 2 3 Other (please specify ) - - example

16 -> Roadmap Critical actions and technical assistance needs to implement the Top 10 indicators of the End TB strategy - Revising national M&E plan - Human resources including manpower, training - Supervision/data audit and feedback - Revise recording and reporting system (e.g. er&r) - Integrate indicators into national health information system

Monitoring top 10 indicators. Philippe Glaziou September 2016

Monitoring top 10 indicators. Philippe Glaziou September 2016 Monitoring top 10 indicators Philippe Glaziou September 2016 Global TB Report 2016 outline top-10 indicators 1. Introduction 2. The SDGs, End TB Strategy and a new era of global TB monitoring 3. TB disease

More information

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities Avinash Kanchar Outline WHO guide to M&E of collaborative TB/HIV activities: 2015 Reporting status on Global

More information

Investing for Impact

Investing for Impact Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,

More information

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information

Session-1: Template for country presentation (EXISTING Indicators)

Session-1: Template for country presentation (EXISTING Indicators) Session-1: Template for country presentation (EXISTING Indicators) Instruction This presentation is expected to provide Country perspective on use of following Existing indicators among the top 10 indicators

More information

Prevention targets & scorecard

Prevention targets & scorecard Prevention targets & scorecard Context Three opportunities For the first time: Global programmatic targets (UN Political Declaration 2016) Translate into pragmatic country road map targets Country and

More information

511,000 (57% new cases) ~50,000 ~30,000

511,000 (57% new cases) ~50,000 ~30,000 Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27

More information

Assessing the programmatic management of drug-resistant TB

Assessing the programmatic management of drug-resistant TB Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many

More information

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and

More information

Updates on the global TB Global TB burden Policy response Treatment approaches

Updates on the global TB Global TB burden Policy response Treatment approaches Ernesto Updates on the global TB Global TB burden Policy response Treatment approaches Ernesto Jaramillo WHO Global TB Programmme World Health Organization, Geneva, Tuberculosis is the leading infectious

More information

Health Situation Room. Introduction to the Concept 2018

Health Situation Room. Introduction to the Concept 2018 Health Situation Room Introduction to the Concept 2018 What is a Health Situation Room? Health Situation Room is an innovative data visualization platform, which allows decision makers and programme

More information

Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan

Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Accra, Ghana May 1 st 2013 Hillary K. Kipruto on behalf of the Kenya team System

More information

HIV Drug Resistance Regional Update Eastern & Southern African Region

HIV Drug Resistance Regional Update Eastern & Southern African Region HIV Drug Resistance Regional Update Eastern & Southern African Region Dr R Banda, IST/ESA Dr F Cham, IST/ESA Dr RG Vaz, WHO AFRO HIVDR Steering Committee Meeting, Geneva 11-12 November 2009 1 Presentation

More information

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the Onion model Ana Bierrenbach WHO consultant Nov/Dec 2010 WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010 Task Force on TB Impact Measurement Mandate To produce a robust,

More information

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS 29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A

More information

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR 2015 2020 Presented by Vincent Habiyambere (WHO), Biyi Adesina (Avenir Health) and Meghan Wareham (CHAI) on behalf

More information

Multidrug-Resistant TB

Multidrug-Resistant TB Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid

More information

Information Note. WHO call for patient data on the treatment of multidrug- and rifampicin resistant tuberculosis

Information Note. WHO call for patient data on the treatment of multidrug- and rifampicin resistant tuberculosis Information Note WHO call for patient data on the treatment of multidrug- and rifampicin resistant tuberculosis In order to ensure that the upcoming comprehensive revision of WHO policies on treatment

More information

Childhood TB and new TB drugs in the WHO European Region

Childhood TB and new TB drugs in the WHO European Region Andrei Dadu Carl Cordonnier Maxim Dondiuk Childhood TB and new TB drugs in the WHO European Region Kigali, Rwanda, 09/10/ 2017 Dr Martin van den Boom, MD, MSc PH, WHO Regional Office for Europe, Joint

More information

Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update

Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update June 3, 2016 On March 10 th, 2015, Médecins Sans Frontières (MSF), ACTION Global Health Advocacy Partnership, SWIFT Response Project, Treatment

More information

Background. events and processes leading up to this meeting

Background. events and processes leading up to this meeting Background events and processes leading up to this meeting Where it began. In some countries, flour fortification started without any baseline information on vitamin and mineral deficiencies In some countries,

More information

UNAIDS 2013 AIDS by the numbers

UNAIDS 2013 AIDS by the numbers UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since

More information

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3

More information

The New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations

The New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations Workshop to accelerate the implementation of the Three Is for HIV/TB and earlier initiation of ART in Southern Africa, March 14-18, 2011, Johannesburg, South Africa. The New WHO guidelines on intensified

More information

Technical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions

Technical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions Technical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions 7-8 November 2013, Geneva Excellent healthcare locally delivered

More information

Latest developments in WHO estimates of TB disease burden

Latest developments in WHO estimates of TB disease burden Latest developments in WHO estimates of TB disease burden WHO Global Task Force on TB Impact Measurement meeting Glion, 1-4 May 2018 Philippe Glaziou, Katherine Floyd 1 Contents Introduction 3 1. Recommendations

More information

WHO Global Task Force on TB Impact Measurement An overview

WHO Global Task Force on TB Impact Measurement An overview WHO Global Task Force on TB Impact Measurement An overview Katherine Floyd (WHO/GTB/TME) 3 rd meeting of the TB estimates subgroup Glion-sur-Montreux, 31March 2 April 2015 GLOBAL TB PROGRAMME 1. Broad

More information

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December

More information

Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia

Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia Monitoring

More information

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations

More information

Appendix 3 Sample size and cost of surveys

Appendix 3 Sample size and cost of surveys Appendix 3 Sample size and cost of surveys Here we estimate the sample sizes needed to carry out prevalence of infection and disease, incidence of disease and verbal autopsy surveys in the 22 high burden

More information

Ending the AIDS Epidemic in Adolescents

Ending the AIDS Epidemic in Adolescents Ending the AIDS Epidemic in Adolescents Eastern and Southern Africa Regional Update on the ALL IN Overview 13 October 2015 AIDS-related deaths has declined for all age groups Except adolescents! Eastern

More information

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic

More information

ASLM Building laboratory capacity in Africa in a sustainable way

ASLM Building laboratory capacity in Africa in a sustainable way ASLM Building laboratory capacity in Africa in a sustainable way Tsehaynesh Messele, PhD ASLM, Chief Executive Officer Annual AMDS meeting September 29-30, 2014 Geneva Laboratory capacity gaps in Africa

More information

Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set

Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set Number of TB notifications and rates, England, 1971-2017 2 Tuberculosis in England: 2018 report, Office

More information

Balancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011

Balancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011 Balancing investment in point of care diagnostics versus laboratory testing in low resource settings Workshop on TB and HIV Diagnostics Workshop on TB and HIV Diagnostics June 28, 2011 Complexity Delivery

More information

Optimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer

Optimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer Optimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer The Public Health need for Palliative Care for Adults and Children with Cancer Dr Emmanuel Luyirika 105M-T3

More information

Tuberculosis prevention: An under prioritized YET critical intervention to reduce child tuberculosis morbidity and mortality

Tuberculosis prevention: An under prioritized YET critical intervention to reduce child tuberculosis morbidity and mortality Tuberculosis prevention: An under prioritized YET critical intervention to reduce child tuberculosis morbidity and mortality Moorine Penninah Sekadde Childhood TB focal point, NTP Uganda Annual meeting

More information

Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:

Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: 1986-2009 Rein Houben/Sebastian Mboma Karonga Prevention Study Incidence of SS+ TB (n/100,000/year

More information

The human immunodeficiency virus/acquired immune

The human immunodeficiency virus/acquired immune Vol. 7(4), pp. 44-48, May 2015 DOI: 10.5897/JAHR2014.0320 Article Number: 70F676253212 ISSN 2141-2359 Copyright 2015 Author(s) retain the copyright of this article http://www.academicjournals.org/jahr

More information

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative 28 October 2008 Geneva 1 CHAI Work in Diagnostics - Context Diagnostic Test Agreements - In 2002 when CHAI was formed, the price of many

More information

USING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa

USING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa USING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa INTEREST 2018 Kigali, Rwanda Emmanuel Njeuhmeli, MD, MPH, MBA Senior Medical Advisor

More information

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS 10 th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource-Limited setting (INTEREST, 3-6 May, 2016) Progress in scaling up HIV prevention and treatment in sub-saharan

More information

Strengthening Lab Capacity for TB Diagnosis and Care in LMICs

Strengthening Lab Capacity for TB Diagnosis and Care in LMICs Strengthening Lab Capacity for TB Diagnosis and Care in LMICs Raising the Bar June 20, 2018 Advanced TB Diagnostics Course McGill University, Montreal Kathleen England, PhD MSc TB Diagnostics Advisor MSF

More information

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation

More information

The epidemiology of tuberculosis

The epidemiology of tuberculosis The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications

More information

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges George Siberry, MD, MPH OGAC Senior Technical Advisor for Pediatrics March, 2016 Compared to Adults, Children (

More information

Certainty assessment of patients Effect Certainty Importance. a standardised 9 month shorter MDR-TB regimen. e f

Certainty assessment of patients Effect Certainty Importance. a standardised 9 month shorter MDR-TB regimen. e f Author(s): STREAM Stage 1 Trial investigators reported for the Guideline Development Group for the WHO treatment guidelines on MDR/RR-TB, 2018 update (6 July 2018) - FINAL RESULTS Question: PICO 1. In

More information

increased efficiency. 27, 20

increased efficiency. 27, 20 Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of

More information

Rapid Diagnostics CHAI Experience. 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012

Rapid Diagnostics CHAI Experience. 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012 Rapid Diagnostics CHAI Experience 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012 CHAI is working in 12 countries on HIV POC test implementation Kenya Tanzania Ethiopia Malawi Mozambique

More information

Global TB control: Current status with particular attention to TB among women and children

Global TB control: Current status with particular attention to TB among women and children Global TB control: Current status with particular attention to TB among women and children Katherine Floyd Stop TB Department World Health Organization 42 nd Union World Conference on Lung Health Stop

More information

: uptake and impact of Xpert MTB/RIF

: uptake and impact of Xpert MTB/RIF Photo: Riccardo Venturi 21-215: uptake and impact of Xpert MTB/RIF Wayne van Gemert WHO Global TB Programme, Geneva Joint Partners Forum for Strengthening and Aligning TB Diagnosis and Treatment 27-3 April

More information

All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON

All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON Amy Slogrove Stellenbosch University 10 th International HIV Pediatrics Workshop

More information

Policies for VMMC in 14 priority countries of east and southern Africa

Policies for VMMC in 14 priority countries of east and southern Africa Policies for VMMC in 14 priority countries of east and southern Africa Andre Verani, JD, MPH Senior Policy Analyst Division of Global HIV and TB Centers for Disease Control and Prevention, Atlanta, USA

More information

Update on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis

Update on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis Update on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis DR-TB Scale-Up Treatment Action Team (DR-TB STAT) October 2017 Content What is DR-TB STAT?

More information

What is new in WHO-guidelines relevant for childhood TB?

What is new in WHO-guidelines relevant for childhood TB? Photo: Riccardo Venturi What is new in WHO-guidelines relevant for childhood TB? Dr Malgosia Grzemska Coordinator, Technical Support, Stop TB Department World Health Organization, Geneva, Switzerland 12th

More information

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Marelize Gorgens mgorgens@worldbank.org The World Bank s Global HIV/AIDS Program

More information

Indicators for MDR-TB detection and outcomes

Indicators for MDR-TB detection and outcomes Indicators for MDR-TB detection and outcomes Dennis FALZON TB surveillance and surveys: A training workshop for consultants Geneva, Switzerland - 26 May 2011 Reference 2 Aggregated forms pages 161 162

More information

TB Disease Prevalence Survey - Progress Report

TB Disease Prevalence Survey - Progress Report TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int

More information

PEPFAR Malawi Baobab Health Trust EMRS

PEPFAR Malawi Baobab Health Trust EMRS PEPFAR Malawi Baobab Health Trust EMRS Leveraging Patient-level Systems for Surveillance & Monitoring September 13, 2017 Johannesburg, South Africa What is the Baobab EMRS System? Modular Point of care

More information

Controlling TB in the era of HIV

Controlling TB in the era of HIV Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population

More information

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Zanzibar

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Zanzibar Policy Brief N um b er 5 ( April 2011) Pupil and Teacher Knowledge about HIV and AIDS in Zanzibar www.sacmeq.org Introduction The HIV and AIDS pandemic presents a major challenge for the social and economic

More information

HIV Viral Load Testing Market Analysis. September 2012 Laboratory Services Team Clinton Health Access Initiative

HIV Viral Load Testing Market Analysis. September 2012 Laboratory Services Team Clinton Health Access Initiative HIV Viral Load Testing Market Analysis September 2012 Laboratory Services Team Clinton Health Access Initiative Agenda Background on Viral Load Testing Growth of Global Viral Load Market Factors Impacting

More information

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org

More information

Progress Report: Universal Access Target Setting in East and Southern Africa

Progress Report: Universal Access Target Setting in East and Southern Africa Progress Report: Universal Access Target Setting in East and Report prepared by: Team for East & 15 September 2006 For all inquiries please contact Mark Stirling, Regional Director for Eastern and, at

More information

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?

More information

Current and future HIV testing approaches and operational implications on testing uptake

Current and future HIV testing approaches and operational implications on testing uptake Current and future HIV testing approaches and operational implications on testing uptake Dr Rachel Baggaley WHO MEETING WITH DIAGNOSTIC MANUFACTURERS AND STAKEHOLDERS GLOBAL FORECASTS OF DIAGNOSTIC DEMAND

More information

Impact Dashboard - October 2014

Impact Dashboard - October 2014 Impact Dashboard - 2014 By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert 198.7 million DALYs, and 56.4%

More information

Impact Dashboard - August 2014

Impact Dashboard - August 2014 Impact Dashboard - By, PSI and its network members averted an estimated 29.7 million DALYs globally. PSI has met 53.3% of the strategic plan (SP) target to avert 198.7 million DALYs, and 53.0% of the SP

More information

Putting the recommendations into action

Putting the recommendations into action 24 May, 2012 Putting the recommendations into action Dr Flavia BUSTREO Assistant Director General, Family, Women s and Children s Health Cluster on behalf of the multi-stakeholder implementation team The

More information

TB Disease Prevalence Survey - Overview, why and how

TB Disease Prevalence Survey - Overview, why and how TB Disease Prevalence Survey - Overview, why and how Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int 3 strategic

More information

AIDS in Africa. An Update. Basil Reekie

AIDS in Africa. An Update. Basil Reekie AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the

More information

World Health Organization 2013

World Health Organization 2013 World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization,

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

Bedaquiline and delamanid Experience of use in children. Bobojon Sharipov Deputy Director of the Republican Tuberculosis Control Centre

Bedaquiline and delamanid Experience of use in children. Bobojon Sharipov Deputy Director of the Republican Tuberculosis Control Centre Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology

More information

Principles and Structure of a Research Protocol. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium

Principles and Structure of a Research Protocol. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium Principles and Structure of a Research Protocol Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium BASIC STRUCTURE Background and rationale to study Aim and objectives (the research question)

More information

Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities

Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities #IAS2017 @IAS_conference Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities Dr. R. Cameron Wolf Senior HIV/AIDS Advisor for Key Populations U.S. Agency for International

More information

World Food Programme (WFP)

World Food Programme (WFP) UNAIDS 2016 REPORT World Food Programme (WFP) Unified Budget Results and Accountability Framework (UBRAF) 2016-2021 2 Contents Achievements 2 Introduction 2 Innovative testing strategies 2 Access to treatment

More information

impact dashboard - june 2018

impact dashboard - june 2018 impact dashboard - june 2018 As of June, PSI averted an estimated 11.3 M DALYs, provided 8.1 M CYPs, and reached 12.5 M users globally. Ethiopia, Zambia, and Cameroon have made considerable progress on

More information

Access to reproductive health care global significance and conceptual challenges

Access to reproductive health care global significance and conceptual challenges 08_XXX_MM1 Access to reproductive health care global significance and conceptual challenges Dr Lale Say World Health Organization Department of Reproductive Health and Research From Research to Practice:

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework

Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework 18 th Wolfheze workshops / 15 th NTP managers meeting, 31 May 02 June 2017 Dr Andrei DADU Technical officer, Joint

More information

impact dashboard - may 2018

impact dashboard - may 2018 impact dashboard - may 2018 As of May, PSI averted an estimated 8.0 M DALYs, provided 6.2 M CYPs, and reached 8.1 M users globally. In May alone, PSI added 2.6 M users toward the goal of 90 M reached by

More information

Monitoring, Evaluation, and Reporting (MER) Guidance (v.2.3): TB and HIV

Monitoring, Evaluation, and Reporting (MER) Guidance (v.2.3): TB and HIV Monitoring, Evaluation, and Reporting (MER) Guidance (v.2.3): TB and HIV Sean Cavanaugh, Senior TB Technical Advisor Office of the U.S. Global AIDS Coordinator & Health Diplomacy August 2018 Video Outline

More information

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa Measurement/indicators of youth employment Gora Mboup Global Urban Observatory (GUO) UN-HABITAT

More information

SOUTH AFRICA S TB BURDEN - OVERVIEW

SOUTH AFRICA S TB BURDEN - OVERVIEW SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB

More information

Update on Meningococcal A Vaccine Development and Introduction

Update on Meningococcal A Vaccine Development and Introduction Update on Meningococcal A Vaccine Development and Introduction WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC) @ Geneva, 7-9 September 2015 Dr Marie-Pierre Preziosi, WHO Initiative

More information

EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN

EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN Anneke C. Hesseling Professor in Paediatrics and Child Health Director: Desmond Tutu TB center Stellenbosch University 11 September 11 th International

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of

More information

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,

More information

Dr Ade Fakoya Senior HIV Advisor

Dr Ade Fakoya Senior HIV Advisor Strengthening community systems to support families, communities and health facilities to prevent parent-to-child transmission and improve the health of women and children Dr Ade Fakoya Senior HIV Advisor

More information

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people

More information

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES 26 November 2015 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fifth session N Djamena, Republic of Chad, 23 27 November 2015 Agenda item 8 PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS

More information

HP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018

HP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018 HP+/Project SOAR Oral PrEP Modeling Webinar Series: Five Ways to Accelerate Progress Toward the 95-95-95 Goals January 16, 2018 Activity Overview 2 Activity Objective Provide impact, cost, and cost-effectiveness

More information

Start Free Stay Free AIDS Free progress report

Start Free Stay Free AIDS Free progress report Start Free Stay Free AIDS Free 217 progress report Copyright 217 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material

More information

Introduction to the Family Planning Financing Roadmap

Introduction to the Family Planning Financing Roadmap Introduction to the Family Planning Financing Roadmap ATTAINING SUSTAINABLE FINANCING FOR FAMILY PLANNING IN SUB-SAHARAN AFRICA ACCRA, JANUARY 2018 Catherine Barker Cantelmo 1 Website Purpose Create an

More information

IMMUNIZATION VACCINE DEVELOPMENT

IMMUNIZATION VACCINE DEVELOPMENT IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION AND POLIO UPDATE IN THE AFRICAN REGION January February 2017 (Vol 5 issue N 1) District data completeness and coverage of DTP3 containing vaccine per

More information

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Mauritius

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Mauritius Policy Brief N um b er 5 ( M ay 2011) Pupil and Teacher Knowledge about HIV and AIDS in Mauritius www.sacmeq.org Introduction The HIV and AIDS pandemic presents a major challenge for the social and economic

More information